BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $60,248,000 | +38.0% | 562,489 | +32.5% | 0.14% | +31.7% |
| Q3 2021 | $43,654,000 | +13.3% | 424,607 | -3.1% | 0.10% | +11.8% |
| Q2 2021 | $38,531,000 | -17.9% | 438,049 | -9.3% | 0.09% | -22.5% |
| Q1 2021 | $46,947,000 | -28.6% | 482,846 | -17.7% | 0.12% | -31.0% |
| Q4 2020 | $65,776,000 | +70.0% | 586,499 | +40.5% | 0.17% | +41.5% |
| Q3 2020 | $38,684,000 | +59.6% | 417,304 | +34.3% | 0.12% | +44.7% |
| Q2 2020 | $24,231,000 | +39.4% | 310,659 | +4.5% | 0.08% | +10.4% |
| Q1 2020 | $17,378,000 | -59.1% | 297,169 | -43.9% | 0.08% | -45.8% |
| Q4 2019 | $42,472,000 | -42.5% | 530,176 | -47.3% | 0.14% | -43.7% |
| Q3 2019 | $73,888,000 | -19.8% | 1,005,683 | +3.0% | 0.25% | -15.7% |
| Q2 2019 | $92,100,000 | +38.4% | 976,359 | +17.5% | 0.30% | +34.7% |
| Q1 2019 | $66,529,000 | +130.5% | 831,099 | +55.2% | 0.22% | +111.4% |
| Q4 2018 | $28,860,000 | -10.1% | 535,343 | +30.2% | 0.10% | +18.0% |
| Q3 2018 | $32,087,000 | -38.8% | 411,061 | -50.2% | 0.09% | -41.8% |
| Q2 2018 | $52,404,000 | -64.1% | 825,518 | -48.2% | 0.15% | -64.7% |
| Q1 2018 | $146,085,000 | +8.6% | 1,593,079 | -10.7% | 0.43% | +13.3% |
| Q4 2017 | $134,482,000 | +9.3% | 1,783,344 | +1.0% | 0.38% | +6.7% |
| Q3 2017 | $122,993,000 | +40.4% | 1,765,366 | +2.1% | 0.36% | +38.1% |
| Q2 2017 | $87,617,000 | +27.4% | 1,729,169 | +0.5% | 0.26% | +26.2% |
| Q1 2017 | $68,793,000 | +127.0% | 1,720,266 | +59.2% | 0.21% | +123.9% |
| Q4 2016 | $30,310,000 | +261.5% | 1,080,574 | +282.8% | 0.09% | +253.8% |
| Q3 2016 | $8,385,000 | +96.6% | 282,303 | +34.1% | 0.03% | +100.0% |
| Q2 2016 | $4,264,000 | +86.1% | 210,581 | +65.9% | 0.01% | +85.7% |
| Q1 2016 | $2,291,000 | -88.4% | 126,904 | -83.1% | 0.01% | -88.3% |
| Q4 2015 | $19,800,000 | +44.3% | 751,715 | +16.9% | 0.06% | +46.3% |
| Q3 2015 | $13,725,000 | -29.5% | 643,162 | -12.5% | 0.04% | -19.6% |
| Q2 2015 | $19,481,000 | – | 735,419 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |